Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michele Jones Calves"'
Autor:
Rita Adluri, Lloyd J. Old, Michele Jones Calves, Herbert F. Oettgen, Shunlin Ren, Gerd Ritter, Philip O. Livingston, Erika Ritter-Boosfeld, Robert K. Yu
Publikováno v:
International Journal of Cancer. 62:668-672
Gangliosides expressed in malignant melanoma are potential targets for immunotherapy. Immunization of melanoma patients with vaccines containing purified GM2 ganglioside has resulted in induction of GM2 antibodies, and high titers of GM2 antibodies h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ace672fac1354097073867a7f7c5bab
https://doi.org/10.1002/ijc.2910620604
https://doi.org/10.1002/ijc.2910620604
Autor:
P. O. Livingston, Gerd Ritter, S Adluri, Michele Jones Calves, F Helling, G Y Wong, C Hanlon, R Parente, M Padavan, Y Tao
Publikováno v:
Journal of Clinical Oncology. 12:1036-1044
PURPOSE To perform a double-blind randomized trial with American Joint Commission on Cancer (AJCC) stage III melanoma patients for the following reasons: (1) to confirm our previous finding that patients with antibodies against the melanoma different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c4da1f21932383bd235eb5d4ae5001d
https://doi.org/10.1200/jco.1994.12.5.1036
https://doi.org/10.1200/jco.1994.12.5.1036
Autor:
Friedhelm Helling, Milan S. Blake, Philip O. Livingston, Michele Jones Calves, George H. Lowell, Wendell D. Zollinger
Publikováno v:
Vaccine. 11(12)
The gangliosides of melanoma and other tumours of neuroectodermal origin are suitable targets for immune intervention with tumour vaccines. The optimal vaccines in current use contain ganglioside plus bacillus Calmette-Guerin and induce considerable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34870509f06a87ff72aff965ce4c49c
https://pubmed.ncbi.nlm.nih.gov/8256501
https://pubmed.ncbi.nlm.nih.gov/8256501
Publikováno v:
Annals of the New York Academy of Sciences. 690
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8214ea4d3a389b7ac0d1f852347a6e3
https://pubmed.ncbi.nlm.nih.gov/8368767
https://pubmed.ncbi.nlm.nih.gov/8368767
Autor:
Philip O. Livingston, Lloyd J. Old, Rita Adluri, Erika Boosfeld, Gerd Ritter, Herbert F. Oettgen, Michele Jones Calves
Publikováno v:
International journal of cancer. 48(3)
GD3 is the ganglioside most abundantly expressed on the cell surface of human melanoma, and treatment with a murine MAb recognizing GD3 has induced major responses in a small proportion of patients with melanoma. We have therefore attempted to induce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22cc77626c2c1e217a35b359da87e6d6
https://pubmed.ncbi.nlm.nih.gov/2040532
https://pubmed.ncbi.nlm.nih.gov/2040532
Autor:
Erika Boosfeld, Herbert F. Oettgen, Gerd Ritter, Michele Jones Calves, Philip O. Livingston, Lloyd J. Old
Publikováno v:
Immunobiology. 182(1)
GD3 is the ganglioside most abundantly expressed on the cell surface of human melanoma, and treatment with a monoclonal antibody recognizing GD3 has induced major responses in a small proportion of patients. However, we have been unable to induce pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23fe82bfb303d13f9be54532f4df3b64
https://pubmed.ncbi.nlm.nih.gov/2098322
https://pubmed.ncbi.nlm.nih.gov/2098322
Autor:
Herbert F. Oettgen, Philip O. Livingston, Lloyd J. Old, Elisabeth Stockert, Michele Jones Calves, Edward J. Natoli
Publikováno v:
Proceedings of the National Academy of Sciences. 84:2911-2915
GM2, GD2, and GD3 gangliosides are expressed on the surface of human melanoma cells and represent potential targets for immunological control of melanoma growth by monoclonal antibodies and active immunization. The immunogenicity of GM2 was investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::887e2013d1dab93f325dc1c1177787ec
https://doi.org/10.1073/pnas.84.9.2911
https://doi.org/10.1073/pnas.84.9.2911
Publikováno v:
Cancer Immunology Immunotherapy. 29
The gangliosides GM2, GD2 and GD3 are differentiation antigens expressed on the cell surface of human melanomas and other cancers of neuroectodermal origin. We have compared the antibody response after vaccination with gangliosides GM1, GM2, GM3, GD2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::601f775bfbad564970904a99093c6e9c
https://doi.org/10.1007/bf00199993
https://doi.org/10.1007/bf00199993